COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
cAMPS-Sp triethylammonium salt (HB0566)
Description:Potent, specific cAMP-dependent protein kinases activator. Cell-permeable.
Purity:>98%
-
CAT335 (HB8146)
Description:K2P2.1 (TREK-1) modulator. Used with ML336 as part of the CATKLAMP chemogenetic strategy. Selectively and irreversibly activates TREK-1CG* but not wild-type K2P2.1 (TREK-1)
Purity:>98%
-
-
Clozapine N-oxide (CNO) (freebase) (HB1807)
Description:Prototypical DREADD activator. Clozapine metabolite.
Purity:>98%
- Description:
Dihydrochloride salt of CNO - the prototypical DREADD activator
Purity:>98%
-
-
-
Diphenhydramine hydrochloride (DPH) (HB2617)
Description:Histamine H1 antagonist. Potent actuator of a modified hM4Di "GRANPA" DREADD receptor.
Purity:>99%
-
1-EBIO (HB1045)
Description:Epithelial KCa channel activator. Promotes ESC differentiation into cardiomyocytes.
Purity:>98%
